Affiliation:
1. Department of Ophthalmology, Medical College of Wisconsin, Milwaukee 53226, USA. wjob@post.its.mcw.edu
Abstract
Prostaglandin A2 (PGA2) inhibited the replication of herpes simplex virus type 1 in rabbit and human cornea stromal cells at concentrations of 1 to 5 microM while causing significant toxicity at 55 to 150 microM. Despite favorable therapeutic indices in cultured cells, PGA2 was not effective as a therapeutic agent in the treatment of herpetic keratitis in a rabbit model. The sequelae of disease appeared more severe in animals receiving PGA2 than in untreated or placebo-treated controls. The recovery of virus from tissues of latently infected rabbits was not affected by therapy. PGA2 therapy alone induced breakdown of the blood-aqueous barrier, indicating that pharmacologically active concentrations of drug were achieved in the eye. Thus, PGA2 had antiviral activity, but its proinflammatory effects appeared to be more detrimental than beneficial in the treatment of herpetic keratitis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference24 articles.
1. Selective inhibition of virus protein synthesis by prostaglandin A1: a translational block associated with HSP70 synthesis;Amici C.;J. Virol.,1994
2. Antiviral activity of prostaglandin A on EMC virus: a unique effect unrelated to interferon;Ankel H.;J. Gen. Virol.,1985
3. Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection;Ankel H.;J. Gen. Virol.,1991
4. Eicosanoids as a new class of ocular hypotensive agents. I. The apparent therapeutic advantages of derived prostaglandins of the A and B type as compared with primary prostaglandins of the E, F, and D type;Bito L.;Exp. Eye Res.,1987
5. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits;Camras C. B.;Invest. Ophthalmol. Visual Sci.,1977
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献